Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2025-12-26 @ 2:43 AM
Study NCT ID:
NCT01277302
Status:
COMPLETED
Last Update Posted:
2014-04-23
First Post:
2011-01-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-13
First Submit QC Date:
None
Study First Post Date:
2011-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-10-17
Results First Submit QC Date:
None
Results First Post Date:
2014-04-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-27
Last Update Post Date:
2014-04-23
Last Update Post Date Type:
ESTIMATED